Connect with us

Health

Could engineered red blood cells be an effective antiviral against SARS-CoV-2? – News-Medical.Net

In a new study, released on the bioRxiv* preprint server, a team of researchers explores the antiviral potential of red blood cells against severe acute respiratory…

Published

on

post featured image

Red blood cells are anucleate cells, which are the most abundant type of cell in the body, being present within all tissues, with a lifespan of 120 days. They also do not have class I major histocompatibility complex molecules, and thus, type O negative RBCs can be used by all patients. This automatically makes them ideal as delivery vehicles for therapeutic molecules, for a range of conditions, including the ongoing coronavirus disease 2019 (COVID-19) pandemic.
In a new study, released on the bioRxiv*…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending